Form 4 Tracker
Andrew Callos

EVP, Chief Commercial Officer · 15 filings · Latest: Jun 1, 2026

CYTOKINETICS INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CYTK
Andrew CallosEVP, Chief Commercial OfficerMar 2, 2026
Sale
$61.62886$54.6K50,440
CYTK
Andrew CallosEVP, Chief Commercial OfficerMar 2, 2026
Option Exercise
$37.63886$33.3K51,326
CYTK
Andrew CallosEVP, Chief Commercial OfficerFeb 5, 2026
Sale
$61.9315,000$929.0K50,440
CYTK
Andrew CallosEVP, Chief Commercial OfficerFeb 5, 2026
Option Exercise
$23.2615,000$348.9K65,440
CYTK
Andrew CallosEVP, Chief Commercial OfficerFeb 2, 2026
Sale
$62.10886$55.0K50,440
CYTK
Andrew CallosEVP, Chief Commercial OfficerFeb 2, 2026
Option Exercise
$37.63886$33.3K51,326
CYTK
ANDREW CALLOSJan 2, 2026
Proposed Sale
$63.5459,570$3.8M
CYTK
ANDREW CALLOSDec 29, 2025
Proposed Sale
$63.111,809$114.2K
CYTK
ANDREW CALLOSDec 5, 2025
Proposed Sale
$66.5453,528$3.6M
CYTK
ANDREW CALLOSApr 7, 2025
Proposed Sale
$37.3615,547$580.8K
CYTK
ANDREW CALLOSMar 14, 2025
Proposed Sale
$44.4021,000$932.4K
CYTK
ANDREW CALLOSMar 13, 2025
Proposed Sale
$43.9926,771$1.2M

← Previous

Page 2 of 2